Nymox Pharmaceutical Corp (NASDAQ:NYMX)

1.52
Delayed Data
As of May 22
 0.00 / 0.00%
Today’s Change
0.33
Today|||52-Week Range
5.75
+280.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues732.6K752.3K735.5K729.1K
 
 
 
 
 
Cost of Goods Sold57.0K48.2K45.4K23.0K
 
 
 
 
 
Depreciation And Amortization1.5K1.5K1.9K1.7K
 
 
 
 
 
 
Operating ExpensesGross Income674.0K702.5K688.2K704.4K
 
 
 
 
 
General Expenses3.4M1.6M1.4M1.4M
 
 
 
 
 
Research And Development2.1M1.1M897.5K737.3K
 
 
 
 
 
Total Operating Expenses3.4M1.6M1.5M1.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-860.7K-734.3K-710.9K
 
 
 
 
 
Extraordinary Credit0.000.000.00189.6K
 
 
Interest Expense On Debt----0.0070.7K
 
 
Other Expenses-8.8K-44.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.7M-904.7K-725.0K-592.0K
 
 
 
 
 
Income Taxes-96.4K-84.4K-36.8K-99.2K
 
 
 
 
 
Net Income-2.6M-820.3K-688.2K-492.8K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.8M35.1M35.4M35.9M
 
 
 
 
 
Shares To Calculate EPS Diluted34.8M35.1M35.4M35.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.02-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.07-$0.02-$0.02-$0.01
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account